TrialEuropean heart journal2023

Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial.

Frederick Raal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.